tm logo

Monitor this mark

View On USPTO

OXERVATE
Live/Registered
SECTION 71 ACCEPTED

on 30 Aug 2022

Last Applicant/ Owned by

DOMPE' FARMACEUTICI S.P.A.

I-20122 MILANO (MI)

IT

Serial Number

79170436 filed on 06th May 2015

Registration Number

4868952 registered on 15th Dec 2015

in the Principal Register

Correspondent Address

Theodore R. Remaklus

Theodore R. Remaklus Wood, Herron & Evans, L.L.P.

Suite 2800

Cincinnati, OH 45202

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

OXERVATE

Pharmaceutical preparations for the treatment of eye diseases and conditions; ophthalmologic preparations

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of eye diseases and conditions; ophthalmologic preparations

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79170436

Mark Type

No Service/Collective Mark

Attorney Docket Number

No BUGNION-184

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
15th Dec 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12th Oct 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
12th Oct 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12th Oct 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30th Aug 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
30th Aug 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30th Aug 2022REGISTERED-SEC.71 ACCEPTED
25th Mar 2022TEAS SECTION 71 RECEIVED
04th Jun 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
12th Feb 2021NEW REPRESENTATIVE AT IB RECEIVED